HK创新药(513120)获融资买入6.05亿元，居两市第27位

Core Viewpoint - HK Innovation Pharmaceuticals (513120) has shown significant financing activity, indicating investor interest and potential market movement [1] Financing Activity - On August 21, HK Innovation Pharmaceuticals recorded a financing buy amount of 605 million yuan, ranking 27th in the two markets [1] - Over the last three trading days (August 19-21), the financing buy amounts were 731 million yuan, 630 million yuan, and 605 million yuan respectively [1] - The net sell amount on August 21 was 933,800 yuan, indicating a slight outflow despite the high financing buy [1] Securities Lending - On August 21, there were no shares sold short, resulting in a net sell of 0 shares [1]